Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Amgen's market standing. Stay informed and make well-considered decisions with our ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Met Éireann says weather warnings "will be issued". Hugh Dooley Storm Éowyn is due to hit Waterford on Thursday night into Friday, Met Éireann has forecast in a national weather advisory. The storm, ...

TOWN OF WATERFORD, Wis. — The Town of Waterford Board voted Monday night to disband its police department. Over the past year, the Waterford Police Department has been without a police chief ...

A large fin whale washed up on the west Waterford coast is believed to have died at sea up to a week ago. The remains of the badly decomposed mammal are thought to have come ashore in the ...

Between 3% and 5% of colorectal cancers exhibit the KRAS G12C mutation. Credit: SewCreamStudio/Shutterstock. Amgen’s LUMAKRAS (sotorasib) and Vectibix (panitumumab ...

The Food and Drug Administration has approved Amgen sotorasib (Lumakras) with panitumumab (Vectibix) for adult patients with KRAS G12C-mutated metastatic colorectal cancer (mCRC), as determined by an ...

Amgen’s Lumakras and AstraZeneca’s Calquence are both in line to expand their respective oncology reaches with new FDA approvals. Calquence, in combination with chemotherapy bendamustine and ...

The U.S. Food and Drug Administration (FDA) gave Amgen (NASDAQ:AMGN) approval to use its KRASG12C inhibitor Lumakras with Vectibix for treating advanced colorectal cancer. Warning! GuruFocus has ...

The FDA on Thursday agreed to expand the label of Amgen’s KRAS inhibitor Lumakras (sotorasib), opening up its use in colorectal cancer. With the latest approval, Lumakras can now be combined with ...